Owner GemVax AS

Inventors Eriksen, Jon Amund; Gaudernack, Gustav; Moller, Mona; Saeboe-Larssen, Stein

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2010200620

Parent 2007211889

Filing date 19 February 2010

Wipo publication date 11 March 2010

Acceptance publication date 1 November 2012

C12N 15/09 Mutation or genetic engineering - Recombinant DNA-technology

A61K 31/7088 - Compounds having three or more nucleosides or nucleotides

A61K 35/14 Medicinal preparations containing material or reaction products thereof with undetermined constitution - Blood

A61K 38/00 Medicinal preparations containing peptides

A61K 38/47 Medicinal preparations containing peptides

A61K 39/00 Medicinal preparations containing antigens or antibodies

A61K 45/00 Medicinal preparations containing active ingredients not provided for in groups

A61K 47/42 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Proteins

A61K 48/00 Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 35/00 Antineoplastic agents

A61P 43/00 Drugs for specific purposes, not provided for in groups

C07K 14/47 Peptides having more than 20 amino acids

C07K 16/40 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against enzymes

C12N 1/15 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 9/12 Enzymes, e.g. ligases (6.) - transferring phosphorus containing groups, e.g. kinases (2.7)

C12Q 1/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids